What SEGOTIA does

SEGOTIA Limited is a private Irish neuro-audio engineering company, incorporated in the Republic of Ireland (registration 612993) and headquartered at Portershed, Bowling Green, Galway. Founded in 2017 by audio IP and software professionals, the company began as an audio integration specialist for hearables, working on audio engineering for mobile apps and System-on-Chip (SoC) hearables platforms, before pivoting to integrate neuroscience-grade EEG sensing into consumer earbuds. Its core technical differentiator is Ear-EEG technology, supported by a custom in-ear EEG prototype validated in collaboration with Trinity College Dublin, that closes the loop between audio delivery and neural sensing for brain-aware applications in sleep, wellness, and cognitive performance.

The company's product surface consists of a hardware Ear-EEG prototype used for validation, Neuro-Audio application software, and a neuro-enabled earbud under development through a 2-year Eurostars-funded R&D consortium that began in April 2024. SEGOTIA operates a B2B technology licensing and co-development model targeting hearable device manufacturers and NeuroTech/sleep technology companies, distributing globally with regional offices in the United States and mainland Europe. Pricing is not publicly disclosed and no commercial revenue figures are available. The company is small (1–10 employees), relies heavily on academic and institutional partnerships (Trinity College Dublin, leading NeuroScience Institutions, CSEM, Eurostars) for R&D validation, and on January 6, 2026 was acquired by US sleep technology firm Ozlo, which intends to use SEGOTIA's EEG stack to transition from hardware to a platform business and enter the medical device market by 2027, including through a partnership with the Calm meditation app.

Name

SEGOTIA

Legal name

SEGOTIA LIMITED

Website

https://segotia.xyz

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

1–10 employees

Short description

SEGOTIA is an Irish neuro-audio engineering company that builds Ear-EEG technology and neuro-adaptive audio software for hearable device manufacturers and NeuroTech customers, and was acquired by OzloSleep in January 2026 to power a sleep and digital health platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Galway

HQ country

Ireland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

SEGOTIA develops audio processing and neurotechnology for hearable devices, combining audio engineering with neuroscience to create brain-aware (Ear-EEG) sensing capabilities integrated into consumer hearables. The company built a validated in-ear EEG prototype, develops neuro-adaptive audio applications, and licenses its Neuro-Audio technology to hearable device manufacturers and NeuroTech companies for sleep, wellness, and cognitive performance use cases.

Product overview

SEGOTIA combines audio processing and neuroscience to drive development of next-generation Hearable Devices and Neuro-adaptive Applications. Their core offerings include an Ear-EEG prototype device, Neuro-Audio Applications for brain-aware hearables, and active development of a neuro-enabled earbud through the Eurostars project. The company integrates neuroscience research and brain wave monitoring capabilities into consumer hearables, closing the loop between audio delivery and neuro sensing, enabling a range of next-generation brain-aware applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Neuro-Audio Applications Brain-aware applications for consumer hearables that integrate EEG sensing with audio delivery, enabling next-generation neuro-adaptive experiences for sleep, wellness, and cognitive performance use cases. Targeted at hearable device manufacturers and NeuroTech companies licensing SEGOTIA's Neuro-Audio platform.
• Ear-EEG Prototype Custom in-ear EEG device prototype developed to validate SEGOTIA's neuro-sensing technology for consumer hearables, built in collaboration with Trinity College Dublin. Used to demonstrate Ear-EEG capabilities to potential licensees and partners.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• OzloflagshipStrategic or Co-development Partner · 6 January 2026SEGOTIA was acquired by Ozlo in January 2026. The acquisition aims to integrate SEGOTIA's EEG technology into Ozlo's sleep and digital health products. Ozlo plans to use SEGOTIA's technology to enter the medical device market by 2027. SEGOTIA's team and technology will contribute to Ozlo's transition from hardware to platform business.
• EurostarscoreStrategic or Co-development Partner · 1 April 2024SEGOTIA participates in a 2-year Eurostars project (starting April 2024) to build a neuro-enabled earbud. Eurostars is a funding program supporting international R&D collaborations.
• Trinity College DublincoreStrategic or Co-development PartnerLong-standing collaboration with Trinity College Dublin for neuroscience research and validation of neuro-enabled earbud technology. Team members include PhD graduates and faculty from Trinity, and Ed Lalor serves as Associate Professor at Trinity College Dublin in the Departments of Biomedical Engineering and Neuroscience.
• CalmcoreTechnology or IntegrationOzlo announced partnership with Calm meditation app as part of its platform strategy. This partnership is being developed under Ozlo's platform business which incorporates SEGOTIA's neuro-audio technology.
• CSEMminorStrategic or Co-development PartnerSEGOTIA evaluated CSEM's ULTEEM in-ear EEG hardware as part of their technology assessment process for neuro-enabled earbuds.
• NeuroScience InstitutionscoreStrategic or Co-development PartnerSEGOTIA collaborates with leading NeuroScience Institutions to discover and prove technologies and commercial opportunities in the Neuro-Audio space.

Recent moves5 records

Expansion highlights5 records

Direct peers

• Muse: Consumer EEG headband company focused on meditation, sleep, and brain-monitoring. Directly comparable to SEGOTIA in targeting brain-sensing for consumer audio/wellness use cases, though using a scalp-EEG form factor rather than in-ear.
• Dreem: Sleep-focused EEG wearable that uses brain-sensing to score and improve sleep. Closely comparable to SEGOTIA in sleep-EEG and Ozlo's distribution pathway; competes for the same consumer sleep-tech wallet.
• Apollo Neuroscience: Neurotech company using audio/visual stimulation through a wearable for sleep, calm, and focus. Closely comparable to SEGOTIA's 'neuro-adaptive audio' thesis of using neuroscience to drive audio interventions.
• Ozlo: US sleep technology firm and SEGOTIA's acquirer (January 2026). Compares as a direct peer/parent because both target sleep-tech consumers with brain-aware hardware and content; SEGOTIA's EEG IP is now embedded inside Ozlo's platform strategy.
• Emotiv: EEG wearables for consumer wellness, research, and B2B applications. Comparable to SEGOTIA in EEG hardware + software stack, though targeting broader BCI/research use cases rather than ear-level hearables.
• Valencell: Licenses biometric sensor technology (PPG, motion, temperature) into hearables and wearables. Directly comparable as a B2B IP licensor enabling sensing features in consumer earbuds — same business model as SEGOTIA's planned hearable-licensing path.

Broad incumbents

• Bose: Major hearables incumbent with consumer sleep-audio products (SleepBuds). Relevant as a potential customer/partner for SEGOTIA's neuro-audio IP and as a competitor with the resources to internalize EEG.
• Apple: AirPods maker with active health/biometric sensing roadmap. Relevant both as a potential hearable OEM customer for SEGOTIA and as the most consequential competitive risk if Apple ships in-ear EEG.
• Sonova: Global hearing-aid leader (Phonak, Unitron) that has begun integrating health/biometric sensors into ear-level devices. Comparable as an ear-level medical-device incumbent with regulatory and distribution scale SEGOTIA lacks.
• NeuroPace: Medical-grade implanted/spiked EEG neurostimulator (RNS System). Comparable as a regulated, EEG-driven medical-device company, illustrating both the regulatory precedent SEGOTIA may face and the regulatory ceiling a sub-scale player must clear.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/segotia

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SEGOTIA